First, we examined the sera from patients with one of five rheumatic diseases—SLE (n = 193), SS (n = 70), RA (n = 84), gout (n = 92), and AS (n = 68)—for IgG and IgM antibodies against CMV (Table 1). This evidence concerns the gene CD40LG and gout.